Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes
Date
2025-04
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Bantounou, M A, Sardellis, P, Plascevic, J, Awaes-Mahmood, R, Kaczmarek, J, Black Boada, D, Thuemmler, R & Philip, S 2025, 'Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes', ESC Heart Failure, vol. 12, no. 2, pp. 968-979. https://doi.org/10.1002/ehf2.15036